As of Feb 12
| +0.03 / +0.88%|
The 1 analysts offering 12-month price forecasts for Cleveland Biolabs Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +1,059.42% increase from the last price of 3.45.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.